LAZARO RABANG: Open Payments
NPI 1649387697 · URBANDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,995 in 126 payments from 23 companies in 2025. Trend: 2023 $2,122 · 2024 $2,696 · 2025 $2,995
Food & beverage: $2,977Education: $19
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $375 |
| Novo Nordisk Inc | 9 | $348 |
| Otsuka America Pharmaceutical, Inc. | 7 | $322 |
| Phathom Pharmaceuticals, Inc. | 11 | $253 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $229 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $228 |
| ABBVIE INC. | 12 | $195 |
| AstraZeneca Pharmaceuticals LP | 12 | $194 |
| Actelion Pharmaceuticals US, Inc. | 3 | $169 |
| Teva Pharmaceuticals USA, Inc. | 2 | $146 |
Products named: REXULTI, VOQUEZNA, JARDIANCE, AUSTEDO XR, Wegovy, Kerendia, UPTRAVI, Ozempic.
Industry payments across IA — which companies pay providers there.
